Pfizer

Pfizer

Yahoo Finance • 11 hours ago

Questex’s DPHARM Announces Senior Leadership and Keynotes for the 16th Annual Conference

Questex LLC BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- DPHARM, the leading innovation event for clinical trial operation executives, announces the 16th annual conference agenda including its senior leadership and keynotes. DPHARM which is... Full story

Yahoo Finance • yesterday

Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income

Quick Read 500 shares each of PFE and JNJ generate $3,540 in annual passive income on a $127,000 investment at a blended 2.79% yield. JNJ's 64th consecutive dividend increase to $1.34 quarterly is backed by a AAA-rated balance sheet and $... Full story

Yahoo Finance • 2 days ago

Want to Retire on $500,000? 3 Stocks to Buy and Never Sell

Key Points Ares Capital offers an especially juicy dividend yield. Energy Transfer enjoys a key tailwind from the ongoing data center build-out. Pfizer expects to maintain and grow its attractive dividend despite facing some challenges.10... Full story

Yahoo Finance • 2 days ago

Novo Nordisk (NYSE:NVO) Launches Pan European Obesity Research Push As Pfizer Closes In

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Novo Nordisk (NYSE:NVO)'s majority owner has launched a large pan European research program focused on obesity and cardiometabolic... Full story

Yahoo Finance • 2 days ago

Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors?

Eli Lilly (NYSE: LLY) is basically hitting it out of the park right now. Sales of its industry-leading GLP-1 weight-loss drugs Mounjaro and Zepbound rose 125% and 80%, respectively, in the first quarter of 2026, driving a huge 56% sales ga... Full story

Yahoo Finance • 4 days ago

Notable Thursday Option Activity: GNRC, FIX, PFE

Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Generac Holdings Inc (Symbol: GNRC), where a total of 4,436 contracts have traded so far, representing approximately 443,600 underlying... Full story

Yahoo Finance • 4 days ago

Top Midday Stories: US, Iran Seal Memorandum to Reopen Hormuz; Intel Gains After Trump Cites Apple Chip Partnership

All three major US stock indexes rose in midday trading Thursday as investors assessed the signing o PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Pfizer CFO Dave Denton stepping down in August 2026

Dave Denton, Pfizer's chief financial officer, is departing the pharmaceutical company for a position in consumer goods, with his last day set for Aug. 15, Pfizer announced Thursday. Stepping into the role on Aug. 16 will be Cecile Guegan... Full story

Yahoo Finance • 4 days ago

FreeCast surges premarket; Accenture, Novocure slide

Investing.com - U.S. stock futures ticked higher on Thursday, as the signing of an interim Middle East peace deal helped ease concerns sparked by the Federal Reserve's hawkish policy outlook. By 0750 ET (11:50 GMT), the Dow futures contra... Full story

Yahoo Finance • 4 days ago

COUR Pharma Announces Closing of $50 Million Series B

CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced today it has closed a $50 million Ser... Full story

Yahoo Finance • 5 days ago

The Number That Could Test Johnson & Johnson Stock

Photo by sasint on Pixabay The company is promising a new era of accelerated growth, but the trajectory of one key cancer drug holds a subtle warning for investors. For a company of its scale, Johnson & Johnson (JNJ) is telling an ambiti... Full story

Yahoo Finance • 5 days ago

Big pharma taps UK playbook to pressure Europe on drug prices

View Comments... Full story

Yahoo Finance • 6 days ago

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28... Full story

Yahoo Finance • 6 days ago

Novo Nordisk to File Oral Wegovy in China

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) rose 0.27% intraday after CEO Mike Doustdar told reporters the company plans to submit oral Wegovy for Chinese regulatory approval "very soon," estimating a timeline of "a... Full story

Yahoo Finance • 6 days ago

How to Build a Retirement Income Plan That Lasts Through a High-Inflation Decade

If you're not factoring inflation into your retirement planning, you'll be kicking yourself years down the road. Even if inflation remains around average -- very roughly 3% -- for the coming 25 years, that's enough to cut the purchasing po... Full story

Yahoo Finance • 6 days ago

DFUV, PFE, NEM, MPC: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Dimensional US Marketwide Value ETF (Symbol: DFUV) where we have detected an approximate $220.6 million dolla... Full story

Yahoo Finance • 7 days ago

Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth

If it weren't for question marks about its future growth, Pfizer (NYSE: PFE) stock would undoubtedly be trading at a much higher price. Sales were down last year, and the stock has been floundering, struggling to gain much traction. Even t... Full story

Yahoo Finance • 7 days ago

Factbox-Global drugmakers invest billions to boost US presence

June 15 (Reuters) - Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and research in the country. Pharmaceutical companies including Eli Lilly, Pfizer, AstraZeneca and Ro... Full story

Yahoo Finance • 8 days ago

Tech Shakeup on the S&P 500

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Jon Quast, Matt Frankel, and Rachel Warren explain what Marvell Technology and Flex do as well as weigh in on whether they could be hidden gems. They also talk... Full story

Yahoo Finance • 9 days ago

How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.

Pharmaceutical giant Bristol Myers Squibb(NYSE: BMY) is offering investors a 4.5% yield. That is well above the 1% you'd collect from the S&P 500 index (SNPINDEX: ^GSPC ) and the 1.6% average for the drug sector. While the yield looks rela... Full story